BUTIROSIN

Possibly Marketed Outside US

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/93616 | https://www.ncbi.nlm.nih.gov/pubmed/81822 |

Butirosin is water-soluble aminoglycosidic antibiotic complex which is active against both Gram-positive and Gram-negative bacteria. Butirosin is less toxic than neomycin and shows a good antibacterial activity, including Pseudomonas aeruginosa, which is resistant to neomycin, ribostamycin and kanamycin.

Approval Year

PubMed

Title	Date	PubMed
Mutational biosynthesis of butirosin analogs. I. Conversion of neamine analogs into butirosin analogs by mutants of Bacillus circulans.	1978-10	81822

Substance Class	Mixture Created by `admin` on `Mon Mar 31 18:39:52 GMT 2025` Edited by `admin` on `Mon Mar 31 18:39:52 GMT 2025`
Record UNII	8S52KR0L58
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BUTIROSIN

Official Name

English

A MIXTURE OF TWO COMPONENTS, BUTIROSIN A (80-85%) AND BUTIROSIN B (15-20%)

Preferred Name

English

butirosin [INN]

Common Name

English

BUTIROSIN [MI]

Common Name

English

AMINOGLYCOSIDIC ANTIBIOTIC COMPLEX OBTAINED FROM FERMENTATION FILTRATES OF MUCOID STRAINS OF BACILLUS CIRCULANS (NRRL B-3312 AND B-3313)

Common Name

English

AMBUTYROSIN

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID60925967